Skip to content

Psychedelic-assisted therapy: all studies

Page 177 of 294: studies 1,761 to 1,770 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

De-Centering the Organism: Psychedelic Therapies, Fungi and the Body without Organs

Polymatheia February 16, 2025 Ernesto Grillo Rabello, Giuliana de Paula Oliveira, Lucas Conforti Protti et al. 1 citation

The encounter of clinical psychology with psychedelic compounds, plants, and mushrooms opens up new possibilities for psychotherapy practices. In the Schizoanalysis of Gilles Deleuze and Félix Guattari, conceptual and experimental tools are found that not only assist in thinking about the psychedelic experience but also enrich clinical practice. The concept of the Body without Organs, which...

BEHAVIORAL AND ELECTROPHYSIOLOGICAL EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN A MOUSE MODEL OF ALCOHOL USE DISORDER (AUD)

The International Journal of Neuropsychopharmacology February 12, 2025 *Danilo De Gregorio, Carolina Giulia Ferroni, Noemi Nicosia et al.

Abstract Introduction Alcohol use disorder (AUD) is a major problem that causes significant health and social problem. Pharmacological treatments for AUD are limited in their effectiveness, and new drugs are required (ref). Recently, the potential use of psychedelics as novel therapies in treating mental diseases has come to the forefront in psychiatry. For instance, lysergic acid diethylamide...

Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländern

edoc Publication server (Humboldt University of Berlin) February 12, 2025 Nina Hartter, Marvin Däumichen, Christopher Schmidt et al.

Hintergrund: Klinische Studien mit Psilocybin in Kombination mit Psychotherapie zeigen vielversprechende Ergebnisse bei der Behandlung verschiedener psychischer Störungen. In der Ärzte- und Psychotherapeutenschaft sowie unter Patient:innen bestehen auch Unwissen, Ablehnung und Vorurteile gegenüber dieser neuen Therapieform. Ziel dieser Studie war es, einen möglichst repräsentativen Eindruck vom...

[Anorexia, bulimia, and binge eating disorder : current situation and future prospects].

Revue Médicale Suisse February 12, 2025 Marco Solcà, Lola De Marcos Fuentes, Marie My Lien Rebetez et al.

Eating is essential to the survival of any living organism. However, beyond simple nutrition, eating is a source of pleasure that awakens a host of emotions and shapes our first relationships. In eating disorders, this vital process becomes a source of psychological distress, with somatic consequences and an impact on the functioning of the individual and his/her environment. Recently, new...

Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders

ACS Pharmacology & Translational Science February 10, 2025 Xue Wang, Cong Lin, Xiaohui Wang 5 citations

Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by deficits in social interaction, communication, and repetitive behaviors. This viewpoint explores the potential mechanisms through which psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 3,4-methylenedioxymethamphetamine (MDMA) may positively influence pro-social behaviors, focusing on...

DOI: 10.1021/acsptsci.5c00034 (opens in new tab) Mental health treatment Psychedelics Autism spectrum disorders Social cognition

The Use of Psychedelics in Chronic Pain – A Scoping Review

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia February 7, 2025 Hugo Santos, Catarina Redinha, Catarina Pereira et al.

Introdução: A dor crónica é uma condição complexa que afeta uma parte significativa da população mundial. As abordagens terapêuticas atuais muitas vezes não são suficientes, o que leva à exploração de novas opções, como os psicadélicos. Objetivos: Mapear e compilar a literatura sobre o uso dos psicadélicos no tratamento da dor crónica, detalhando as características dos estudos, as populações...

A qualitative analysis of the psychedelic mushroom come-up and come-down.

npj Mental Health Research February 7, 2025 Ari Brouwer, Joshua K Brown, Earth Erowid et al. 5 citations

Psychedelic therapy has the potential to become a revolutionary and transdiagnostic mental health treatment, yielding enduring benefits that are often attributed to the experiences that coincide with peak psychedelic effects. However, there may be an underrecognized temporal structure to this process that helps explain why psychedelic and related altered states of consciousness can have an...

DOI: 10.1038/s44184-024-00095-6 (opens in new tab) Full text (opens in new tab) Stress relief Psychedelics Mental health Altered states +1

Social Worker Attitudes towards Psychedelics

Clinical Social Work Journal February 6, 2025 Eva Nowakowski-Sims, Joshua Holzworth 1 citation

Abstract The use of psychedelics in treating mental health disorders is gaining attention due to a growing evidence base and pending FDA approval. Very little is known regarding what social workers know and how they feel about psychedelics as a treatment for mental health disorders. The purpose of this study was to explore social worker attitudes towards psychedelics and social worker knowledge...

The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials

Medicina February 6, 2025 Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea et al. 14 citations

Background and Objectives: Substance use disorders (SUDs) affect millions worldwide. Despite increasing drug use, treatment options remain limited. Psychedelic-assisted therapy (PAT), integrating psychedelic substances with psychotherapy, offers a promising alternative by addressing underlying neural mechanisms. Materials and Methods: This review’s purpose is to investigate the current...

DOI: 10.3390/medicina61020278 (opens in new tab) Substance use Clinical trial Psychotherapist

That men should put an enemy in their mouths to steal away their brains: Reconsidering the origins of model psychosis.

History of the Human Sciences February 1, 2025 Matthew Perkins-McVey

The promises of the Prozac century have fallen short; the number of novel, therapeutically significant medications successfully completing development shrinks every year; and the demand for better treatments constantly grows. Answering these hardships is a renewed optimism concerning the efficacy of controlled psychedelic therapy, a renaissance that has seen the resurgence of a familiar...

DOI: 10.1177/09526951241286744 (opens in new tab) Full text (opens in new tab) Kraepelin Mental illness Model psychosis Pharmaceutical industry +1